Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Warts × Tuberculin × Clear all

Phase

Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

plerixafor 1 Tuberculin 1 Salicylic Acid 1 Pyruvic Acid 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05254561 2022-02-24

Triple Antigen vs Monoantigen Immunotherapy for Warts

Zagazig University

Phase 2/3 Completed

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡